Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Colorectal Cancer

被引：0

作者：

Soh, Thomas ^{[1
]}

Chua, Clarinda W. L. ^{[2
]}

Tan, Iain B. H. ^{[2
]}

Chong, Dawn ^{[1
]}

Chuah, Benjamin ^{[3
]}

Kong, Loong ^{[4
]}

Poon, Donald ^{[5
]}

Toh, Han Chong ^{[2
]}

Yeo, Wee Lee ^{[6
]}

Yong, Wei Peng ^{[1
]}

Zee, Ying Kiat ^{[7
]}

机构：

[1] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore

[2] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore 169610, Singapore

[3] Oncocare Canc Ctr, Singapore, Singapore

[4] HL Kong Med Oncol Ctr, Singapore, Singapore

[5] Raffles Canc Ctr, Med Oncol, Singapore, Singapore

[6] Tan Tock Seng Hosp, Dept Med Oncol, Singapore, Singapore

[7] Pkwy Canc Ctr, Med Oncol, Singapore, Singapore

来源：

ANNALS ACADEMY OF MEDICINE SINGAPORE | 2015年 / 44卷 / 10期

关键词：

Treatment recommendations; Multidisciplinary; Malignancy; RANDOMIZED CONTROLLED-TRIAL; COLON-CANCER; ADJUVANT THERAPY; STAGE-II; CHEMOTHERAPY; FLUOROURACIL; OXALIPLATIN; CETUXIMAB;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: The SCAN colorectal cancer systemic therapy workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for systemic therapy for colorectal cancer in Singapore. Materials and Methods: The workgroup utilised a modified ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. Results: Five international guidelines were evaluated-those developed by the National Comprehensive Cancer Network for colon (2014) and rectal (2014) cancer, the European Society of Medical Oncology for advanced (2012) and early (2013) cancer and the National Institute of Clinical Excellence (2011). Recommendations on systemic therapy in colorectal cancer were produced. Conclusion: These adapted guidelines form the SCAN Guidelines 2015 for systemic therapy of colorectal cancer.

引用

页码：379 / 387

页数：9

共 20 条

[1]

[Anonymous], COL CANC DIAGN MAN C

[2]

[Anonymous], NCCN GUID COL CANC V

[3]

[Anonymous], NCCN GUID RECT CANC

[4] Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer [J].

Erlichman, C ;

O'Connell, M ;

Kahn, M ;

Marsoni, S ;

Torri, V ;

Tardio, B ;

Zaniboni, A ;

Pancera, G ;

Martignoni, G ;

Labianca, R ;

Barni, A ;

Seitz, JF ;

Milan, C ;

Bedenne, L ;

Giovannini, M ;

Letreut, YP ;

Skillings, J ;

Shepard, L ;

Zee, B ;

Petrioli, R ;

Francini, G .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1356-1363

[5] Adaptation of clinical guidelines: literature review and proposition for a framework and procedure [J].

Fervers, Beatrice ;

Burgers, Jako S. ;

Haugh, Margaret C. ;

Latreille, Jean ;

Mlika-Cabanne, Najoua ;

Paquet, Louise ;

Coulombe, Martin ;

Poirier, Mireille ;

Burnand, Bernard .

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2006, 18 (03) :167-176

[6] Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much? [J].

Gill, S ;

Loprinzi, CL ;

Sargent, DJ ;

Thomé, SD ;

Alberts, SR ;

Haller, DG ;

Benedetti, J ;

Francini, G ;

Shepherd, LE ;

Seitz, JF ;

Labianca, R ;

Chen, W ;

Cha, SS ;

Heldebrant, MP ;

Goldberg, RM .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1797-1806

[7] Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study [J].

Gray, Richard ;

Barnwell, Jennifer ;

McConkey, Christopher ;

Hills, Robert K. ;

Williams, Norman S. ;

Kerr, David J. .

LANCET, 2007, 370 (9604) :2020-2029

[8]

Koopman M, 2014, J CLIN ONCOL S, V32, p5s

[9] Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Labianca, R. ;

Nordlinger, B. ;

Beretta, G. D. ;

Mosconi, S. ;

Mandala, M. ;

Cervantes, A. ;

Arnold, D. .

ANNALS OF ONCOLOGY, 2013, 24 :64-72

[10]

National Institute for Health and Care E xcellence, CET BEV PAN TREATM M

← 1 2 →